Home care is not a flashy corner of the healthcare industry, but it is becoming one of the more consequential ones. When medically complex patients, particularly children with chronic conditions, can receive skilled nursing care at home instead of in a hospital, costs fall, outcomes often improve, and families stay together. That shift is exactly what Atlanta-based Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has been building toward, and the company’s latest move reflects just how deliberately it is executing on that strategy.
Aveanna completed the acquisition of Family First Homecare, a multi-state provider of pediatric Private Duty Nursing services, for a cash purchase price of $175.5 million. The entire amount came from cash on hand, with no debt drawn down to fund the deal. Family First Homecare operates 27 locations across seven states, including Florida, Illinois, Iowa, North Carolina, Pennsylvania, South Dakota, and Texas, and its services focus on skilled nursing care for children with serious medical needs. The acquisition expands Aveanna’s geographic footprint and adds meaningful density in several states where it already operates.
The timing of the guidance update matters as much as the deal itself. On the same day the acquisition closed, Aveanna raised its full-year 2026 revenue guidance from a range of $2.56 to $2.58 billion up to a range of $2.63 to $2.65 billion, an increase of $70 million attributed entirely to Family First Homecare’s expected contribution through the end of the fiscal year on January 2, 2027. Adjusted EBITDA guidance was also raised, moving from a range of $328 to $332 million up to $338 to $342 million, with the $10 million increase again tied directly to the acquisition. Because the deal is already closed rather than pending, these are not aspirational projections but revisions grounded in a completed transaction.
For those that track small-cap healthcare names, Aveanna’s story over the past several quarters has been one of genuine financial improvement. Revenue grew 15.9% year over year in the first quarter of 2026, while Adjusted EBITDA rose 25.2% over the same period, reflecting both stronger reimbursement rates and higher volumes under what the company calls its preferred-payer strategy. A preferred-payer agreement, in plain terms, is a contract between a home care provider and a state Medicaid program or managed care organization in which the provider is designated as a preferred or priority network partner. This typically means higher and more predictable reimbursement rates in exchange for meeting quality and outcome standards, which rewards providers who consistently deliver measurable results. Aveanna has accumulated over 100 such agreements, and that pipeline is translating directly into margin improvement.
The broader context here is demographic and structural. The U.S. population of medically complex pediatric patients, children who require ongoing skilled nursing to remain safely at home, is not shrinking. State and federal Medicaid programs have strong financial incentives to keep these patients out of hospitals and long-term care facilities, and companies that can deliver consistent, high-quality home-based care at scale are finding themselves with growing pricing power and volume. Aveanna now operates across 39 states with approximately 29,000 caregivers, and the addition of Family First Homecare’s 27 locations deepens its reach in several high-population markets.
What makes the Family First transaction worth noting beyond the headline number is the capital discipline behind it. Paying $175.5 million entirely from cash on hand, without tapping credit facilities, preserves the company’s financial flexibility and signals management’s confidence in its cash generation. The guidance increase, tied directly to a closed deal rather than a hoped-for one, gives the revised numbers a credibility that speculative forecasts rarely carry. For a small-cap company still trading at a significant discount to larger home health peers, that combination of execution and financial transparency is precisely the kind of signal longer-term investors tend to notice.
